다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BOLD

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2018/05/02	21:00	PR Newswire (US)	Audentes Therapeutics to Release First Quarter 2018 Financial Results and Provide Corporate Update on Wednesday, May 9, 2018	NASDAQ:BOLD	Boundless Bio Inc
2018/05/01	02:14	PR Newswire (US)	Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American Society of Gene and Cell Ther...	NASDAQ:BOLD	Boundless Bio Inc
2018/04/28	06:57	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BOLD	Boundless Bio Inc
2018/04/28	06:56	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BOLD	Boundless Bio Inc
2018/04/24	02:40	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/30	05:53	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/13	07:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/10	07:30	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/09	06:27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/09	06:01	PR Newswire (US)	Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
2018/03/07	07:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/03/06	22:00	PR Newswire (US)	Audentes Therapeutics to Present at the Cowen 38th Annual Health Care Conference	NASDAQ:BOLD	Boundless Bio Inc
2018/03/01	22:00	PR Newswire (US)	Audentes Therapeutics to Release Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update on Thursday...	NASDAQ:BOLD	Boundless Bio Inc
2018/02/28	22:00	PR Newswire (US)	Audentes Therapeutics Joins Global Organizations In Recognizing Rare Disease Day® 2018	NASDAQ:BOLD	Boundless Bio Inc
2018/02/15	04:24	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/15	03:08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/14	22:47	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/14	06:45	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/14	06:06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/14	05:09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/13	23:38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/13	00:01	Edgar (US Regulatory)	Schedule 13g	NASDAQ:BOLD	Boundless Bio Inc
2018/02/12	22:00	PR Newswire (US)	Audentes Therapeutics Announces Dosing of First Patient in VALENS, a Phase 1/2 Clinical Trial of AT342 for the treatment of C...	NASDAQ:BOLD	Boundless Bio Inc
2018/02/09	03:57	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/02/08	22:00	PR Newswire (US)	Audentes Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc
2018/02/07	09:30	PR Newswire (US)	Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program	NASDAQ:BOLD	Boundless Bio Inc
2018/01/30	06:01	PR Newswire (US)	Audentes Therapeutics Announces the Closing of its Public Offering and Full Exercise of the Underwriters' Option to Purchase ...	NASDAQ:BOLD	Boundless Bio Inc
2018/01/26	06:15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/01/26	06:10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:BOLD	Boundless Bio Inc
2018/01/25	09:43	PR Newswire (US)	Audentes Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:BOLD	Boundless Bio Inc

검색 관련기사 보기:NASDAQ:BOLD

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

Invesco QQQ Trust Series 1

American Express

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관